Bath & Body Works, Inc. $BBWI Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 35.9% during the third quarter, Holdings Channel.com reports. The firm owned 45,704 shares of the company’s stock after selling 25,625 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Bath & Body Works were worth $1,174,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in BBWI. First Horizon Corp bought a new stake in shares of Bath & Body Works in the 3rd quarter worth $29,000. Stonehage Fleming Financial Services Holdings Ltd acquired a new stake in Bath & Body Works during the 2nd quarter worth about $33,000. Geneos Wealth Management Inc. raised its holdings in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Carolina Wealth Advisors LLC acquired a new stake in Bath & Body Works during the 3rd quarter valued at $54,000. Finally, Parkside Financial Bank & Trust lifted its stake in Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after acquiring an additional 364 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Up 5.1%

Shares of Bath & Body Works stock opened at $21.79 on Monday. The stock has a market capitalization of $4.46 billion, a P/E ratio of 6.70, a price-to-earnings-growth ratio of 0.79 and a beta of 1.54. The company has a 50-day simple moving average of $20.39 and a 200 day simple moving average of $24.68. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the company earned $0.49 earnings per share. The firm’s revenue was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.7%. The ex-dividend date of this dividend was Friday, November 21st. Bath & Body Works’s dividend payout ratio (DPR) is 24.62%.

Insider Transactions at Bath & Body Works

In related news, Director Francis Hondal acquired 3,343 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average price of $14.99 per share, for a total transaction of $50,111.57. Following the completion of the acquisition, the director owned 21,554 shares of the company’s stock, valued at $323,094.46. This trade represents a 18.36% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Lucy Brady acquired 3,470 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average price of $14.40 per share, with a total value of $49,968.00. Following the acquisition, the director owned 17,482 shares of the company’s stock, valued at approximately $251,740.80. This trade represents a 24.76% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders bought 33,513 shares of company stock valued at $500,442. 0.27% of the stock is owned by company insiders.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Neutral Sentiment: Context on recent operating results and analyst commentary — a recent industry roundup revisits Bath & Body Works’ Q3 earnings and may inform investor views on fundamentals rather than litigation. Reflecting on beauty and cosmetics retailer stocks’ Q3 earnings: Bath and Body Works (NYSE:BBWI)
• Negative Sentiment: Multiple securities class actions filed / law firms soliciting plaintiffs — firms (e.g., Gainey McKenna & Egleston, Kessler Topaz, Glancy Prongay Wolke & Rotter and others) say suits were filed on behalf of investors who bought BBWI between June 4, 2024 and Nov 19, 2025, alleging material misstatements/omissions tied to a sharp Nov. 19 share drop. These notices increase litigation risk and could lead to settlements, higher legal costs, management distraction and investor uncertainty. Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bath & Body Works, Inc. (BBWI) Kessler Topaz Meltzer & Check, LLP Encourages Bath & Body Works, Inc. Investors with Losses to Contact the Firm Deadline Alert: Glancy Prongay Wolke & Rotter LLP
• Negative Sentiment: Deadlines and scale — several firms cite lead?plaintiff filing deadlines in mid?March (March 13–16, 2026). The breadth of solicitations (many firms contacting investors) suggests sustained media/legal attention, which can prolong volatility and keep a risk premium on the shares until claims are resolved or dismissed. Faruqi & Faruqi, LLP Investigates Claims

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Jefferies Financial Group started coverage on shares of Bath & Body Works in a research report on Wednesday, January 14th. They issued a “hold” rating and a $24.00 target price for the company. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Wells Fargo & Company decreased their price target on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, November 21st. Deutsche Bank Aktiengesellschaft began coverage on Bath & Body Works in a research report on Thursday, January 8th. They issued a “hold” rating and a $21.00 price objective for the company. Finally, Citigroup reduced their target price on shares of Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a research note on Friday, November 21st. Five research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Hold” and an average price target of $23.53.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.